BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 10, 2026
Home
»
Newsletters
» BioWorld
BioWorld
Sep. 27, 2000
View Archived Issues
Appointments and Advancements
Read More
Immunomedics Begins Phase III Of LymphoCide For Lymphoma
Read More
Dynavax Raises $22.6M To Fund Immune Therapies Development
Read More
NeoPharm Raises $106M Publicly To Support Oncology Pipeline
Read More
Other News To Note
Read More
Correction (Article Updated in Database)
Read More
PDL Exceeds Expectation With $355M Offering Of 3M Shares
Read More
Novartis Dedicates $30M To BioTransplant Joint Venture
Read More
Positional Cloning By International Team Finds Susceptibility Gene For Complex Diabetes Mellitus Type II
Read More
Cell Therapeutics Gets FDA Approval For Leukemia Drug
Read More
